APC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418
C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
  • N418
    C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
117309 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117310 100 µg 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  4. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  5. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  6. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  7. Minute L, et al. 2020. J Immunother Cancer. 8:. PubMed
  8. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  9. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  10. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  11. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  12. Gujar R, et al. 2016. J Immunol. 197: 1650 - 1662. PubMed
  13. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  14. Riva A, et al. 2013. J Immunol. 190:5961. PubMed
  15. Kitai H, et al. 2022. BMC Biol. 20:248. PubMed
  16. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  17. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  18. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  19. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  20. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  21. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  22. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  23. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  24. Page N, et al. 2018. Immunity. 48:937. PubMed
  25. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  26. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  27. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  28. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  29. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  30. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  31. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  32. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  33. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  34. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  35. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  36. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  37. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  38. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  39. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  40. Wegmann F, et al. 2015. Clin Vaccine Immunol. 22: 1004-1012. PubMed
  41. Qian F, et al. 2015. J Mol Cell Biol. . PubMed
  42. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  43. Wiernicki B, et al. 2022. Nat Commun. 13:3676. PubMed
  44. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  45. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  46. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  47. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  48. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  49. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  50. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  51. Shin M et al. 2019. Cell Chem Biol. 26(7):1036-1041 . PubMed
  52. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  53. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  54. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  55. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  56. Prado C, et al. 2012. J Immunol. 188:3062. PubMed
  57. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  58. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  59. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  60. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  61. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  62. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  63. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  64. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  65. O'Shea NR, Chew TS 2016. J Crohns Colitis. 10(12):1417-1427. PubMed
  66. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  67. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  68. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  69. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  70. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  71. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  72. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  73. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  74. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  75. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  76. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  77. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  78. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  79. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  80. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  81. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  82. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  83. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  84. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  85. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  86. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  87. Ustarroz-Cano M, et al. 2012. J Immunotoxicol. 9:374. PubMed
  88. Bak S, et al. 2008. Mol Immunol. 45:1414. PubMed
  89. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  90. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  91. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  92. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  93. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  94. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  95. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  96. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  97. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  98. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  99. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  100. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  101. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  102. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  103. Li N, et al. 2021. eLife. 10:00. PubMed
  104. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  105. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  106. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  107. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  108. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  109. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  110. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  111. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  112. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  113. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  114. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  115. Liu M, et al. 2016. PLoS One. 11:e0166165. PubMed
  116. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  117. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  118. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  119. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  120. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  121. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  122. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  123. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  124. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  125. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  126. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  127. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  128. White C, et al. 2015. J Immunol. 194:697. PubMed
  129. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  130. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  131. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  132. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  133. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  134. Yang Y, et al. 2021. Sci Adv. 7:eabf6290. PubMed
  135. Kim S, et al. 2021. Elife. 10:. PubMed
  136. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  137. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  138. He J, et al. 2019. J Clin Invest. 130. PubMed
  139. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  140. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  141. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  142. Marsh L, et al. 2009. Am J Physiol Lung Cell Mol Physiol. 296:L442. PubMed
  143. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  144. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  145. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  146. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  147. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  148. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  149. Lang V, et al. 2021. Elife. 10:. PubMed
  150. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  151. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  152. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  153. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  154. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  155. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  156. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  157. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  158. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  159. Tukaramrao DB, et al. 2021. Cancers (Basel). 13:. PubMed
  160. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  161. Schneider KM, et al. 2022. Nat Commun. 13:3964. PubMed
  162. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  163. Wang Y, et al. 2022. J Control Release. 349:118. PubMed
  164. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  165. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  166. Trinh HKT, et al. 2019. J Cell Mol Med. 23:3441. PubMed
  167. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  168. Zhao L, et al. 2021. STAR Protocols. 2(3):100732. PubMed
  169. Peng X, et al. 2016. J Cell Sci. 129: 1831 - 1842. PubMed
  170. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  171. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  172. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  173. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  174. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  175. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  176. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  177. Yamada S, et al. 2018. Arterioscler Thromb Vasc Biol. 38:994. PubMed
  178. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  179. Berthold N, et al. 2013. Antimicrob Agents Chemother. 57:402. PubMed
  180. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  181. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  182. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  183. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  184. Li C, et al. 2018. Cell. 174:285. PubMed
  185. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  186. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  187. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  188. Zhao W, et al. 2014. Clin Vaccine Immunol. 21:74. PubMed
  189. Qian Z, et al. 2022. Biomedicines. 10:. PubMed
  190. Bezu L, et al. 2022. J Immunother Cancer. 10:. PubMed
  191. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  192. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  193. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  194. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  195. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  196. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  197. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  198. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  199. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  200. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  201. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  202. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  203. Takahashi N, et al. 2022. Tohoku J Exp Med. 257:171. PubMed
  204. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  205. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  206. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  207. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  208. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  209. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  210. Ryu S, et al. 2021. eLife. 0.416666666666667. PubMed
  211. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  212. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  213. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  214. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  215. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  216. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  217. Smith LK, et al. 2021. Elife. 10:. PubMed
  218. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  219. Li H, et al. 2022. iScience. 25:104481. PubMed
  220. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  221. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  222. Nicholls J, et al. 2021. Front Cell Dev Biol. 9:737880. PubMed
  223. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  224. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  225. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  226. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  227. Gentschev I, et al. 2012. PLoS One. 7:e37239. PubMed
  228. Zhang B, et al. 2021. Nature. 599:471. PubMed
  229. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  230. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  231. Gawish R, et al. 2022. Elife. 11:. PubMed
  232. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  233. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  234. Matisz CE, et al. 2018. Am J Pathol. 188:2589. PubMed
  235. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  236. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  237. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  238. Yu L, et al. 2022. Front Immunol. 13:937331. PubMed
  239. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  240. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  241. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  242. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  243. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  244. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
  245. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  246. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  247. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  248. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
RRID
AB_313778 (BioLegend Cat. No. 117309)
AB_313779 (BioLegend Cat. No. 117310)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC, IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC, CyTOF®, IP, IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC, IHC, ICC, 3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC, IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC, CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F, 3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

  • Spark UV™ 387 anti-mouse CD11c

  • Spark Red™ 718 anti-mouse CD11c

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account